Net Loss Per Share (Tables)

9 Months Ended

Sep. 30, 2024

Earnings Per Share [Abstract]

Schedule of Anti-dilutive Equity Instruments Excluded from Calculation of Diluted Net Loss Per Share

The following equity instruments were excluded from the calculation of diluted net loss per share because their effect would have been anti-dilutive for the periods presented:


		Nine months ended September 30,
		2024				2023
Awards under equity incentive plan			9,478,496				8,551,117
Non-vested restricted shares and restricted stock units			3,753,562				2,281,812
Warrants to purchase common stock(*)			77,793				77,793
Total			13,309,851				10,910,722

* Pre-funded warrants are excluded herein.

Reconciles Basic Earnings Per Share and Diluted Earnings Per Share of Common Stock

The following table calculates basic earnings per share of common stock and diluted earnings per share of common stock for the three and nine months ended September 30, 2024 and 2023 (in thousands, except share and per share amounts):


		Three months ended September 30,								Nine months ended September 30,
		2024				2023				2024				2023
Net loss		$	(24,248	)		$	(16,599	)		$	(66,837	)		$	(38,599	)
Net loss attributable to common stockholders			(24,248	)			(16,599	)			(66,837	)			(38,599	)
Weighted-average common shares outstanding, basic and diluted			211,847,651				174,696,191				192,398,514				152,778,072
Basic and diluted EPS		$	(0.11	)		$	(0.10	)		$	(0.35	)		$	(0.25	)